Trial
NCT02343666
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)
Condition
Human Immunodeficiency Virus 1 Positive
Intervention
C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs
Why stopped
Administrative closure prior to any enrollments
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-20